1
|
Vulcanescu DD, Bagiu IC, Avram CR, Oprisoni LA, Tanasescu S, Sorescu T, Susan R, Susan M, Sorop VB, Diaconu MM, Dragomir TL, Harich OO, Horhat RM, Dinu S, Horhat FG. Bacterial Infections, Trends, and Resistance Patterns in the Time of the COVID-19 Pandemic in Romania-A Systematic Review. Antibiotics (Basel) 2024; 13:1219. [PMID: 39766609 PMCID: PMC11726834 DOI: 10.3390/antibiotics13121219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2024] [Revised: 11/16/2024] [Accepted: 12/12/2024] [Indexed: 01/05/2025] Open
Abstract
Background: The COVID-19 pandemic has intensified concerns over bacterial infections and antimicrobial resistance, particularly in Romania. This systematic review explores bacterial infection patterns and resistance during the pandemic to address critical gaps in knowledge. Methods: A systematic review, following PRISMA guidelines, was conducted using databases such as PubMed and Scopus, focusing on studies of bacterial infections from 2020 to 2022. Articles on bacterial infections in Romanian patients during the pandemic were analyzed for demographic data, bacterial trends, and resistance profiles. Results: A total of 87 studies were included, detailing over 20,000 cases of bacterial infections. The review found that Gram-negative bacteria, particularly Escherichia coli and Klebsiella pneumoniae, were the most frequently identified pathogens, alongside Gram-positive Staphylococcus aureus and Enterococcus spp. Multidrug resistance (MDR) was noted in 24% of the reported strains, with common resistance to carbapenems and cephalosporins. Conclusions: The pandemic has amplified the complexity of managing bacterial infections, particularly in critically ill patients. The rise in MDR bacteria underscores the need for stringent antimicrobial stewardship and infection control measures. Continuous monitoring of bacterial trends and resistance profiles will be essential to improve treatment strategies in post-pandemic healthcare settings.
Collapse
Affiliation(s)
- Dan Dumitru Vulcanescu
- Department of Microbiology, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania; (D.D.V.); (I.C.B.); (F.G.H.)
- Multidisciplinary Research Center on Antimicrobial Resistance (MULTI-REZ), Microbiology Department, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania
- Doctoral School, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania
| | - Iulia Cristina Bagiu
- Department of Microbiology, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania; (D.D.V.); (I.C.B.); (F.G.H.)
- Multidisciplinary Research Center on Antimicrobial Resistance (MULTI-REZ), Microbiology Department, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania
| | - Cecilia Roberta Avram
- Department of Residential Training and Post-University Courses, “Vasile Goldis” Western University, 310414 Arad, Romania
| | - Licinia Andrada Oprisoni
- Department of Pediatrics, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania; (L.A.O.); (S.T.)
| | - Sonia Tanasescu
- Department of Pediatrics, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania; (L.A.O.); (S.T.)
| | - Teodora Sorescu
- Department of Internal Medicine II: Diabetes, Nutrition, Metabolic Diseases, and Systemic Rheumatology, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania;
- Department of Diabetes, Nutrition and Metabolic Diseases, “Pius Brînzeu” Emergency Clinical County University Hospital, 300723 Timisoara, Romania
| | - Razvan Susan
- Department of Family Medicine, Centre for Preventive Medicine, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania;
| | - Monica Susan
- Department of Internal Medicine I, Centre for Preventive Medicine, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania;
| | - Virgiuliu Bogdan Sorop
- Department of Obstetrics and Gynecology, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania; (V.B.S.); (M.M.D.)
| | - Mircea Mihai Diaconu
- Department of Obstetrics and Gynecology, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania; (V.B.S.); (M.M.D.)
| | - Tiberiu Liviu Dragomir
- Medical Semiology II Discipline, Internal Medicine Department, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania;
| | - Octavia Oana Harich
- Department of Functional Sciences, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania;
| | - Razvan Mihai Horhat
- Department of Restorative Dentistry, Faculty of Dentistry, Digital and Advanced Technique for Endodontic, Restorative and Prosthetic Treatment Research Center (TADERP), “Victor Babes” University of Medicine and Pharmacy, Revolutiei Bv. No. 9, 300041 Timișoara, Romania;
| | - Stefania Dinu
- Department of Pedodontics, Faculty of Dental Medicine, “Victor Babes” University of Medicine and Pharmacy Timisoara, Revolutiei Bv. No. 9, 300041 Timisoara, Romania;
- Pediatric Dentistry Research Center, Faculty of Dental Medicine, “Victor Babes” University of Medicine and Pharmacy Timisoara, Revolutiei Bv. No. 9, 300041 Timisoara, Romania
| | - Florin George Horhat
- Department of Microbiology, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania; (D.D.V.); (I.C.B.); (F.G.H.)
- Multidisciplinary Research Center on Antimicrobial Resistance (MULTI-REZ), Microbiology Department, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania
| |
Collapse
|
2
|
Rozhin A, Batasheva S, Iskuzhina L, Gomzikova M, Kryuchkova M. Antimicrobial and Antifungal Action of Biogenic Silver Nanoparticles in Combination with Antibiotics and Fungicides Against Opportunistic Bacteria and Yeast. Int J Mol Sci 2024; 25:12494. [PMID: 39684204 PMCID: PMC11641717 DOI: 10.3390/ijms252312494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2024] [Revised: 08/26/2024] [Accepted: 08/27/2024] [Indexed: 12/18/2024] Open
Abstract
The development of multidrug resistance by pathogenic bacteria and yeast is a significant medical problem that needs to be addressed. One possible answer could be the combined use of antibiotics and silver nanoparticles, which have different mechanisms of antimicrobial action. In the same way, these nanoparticles can be combined with antifungal agents. Biogenic silver nanoparticles synthesized using environmentally friendly biosynthesis technology using extracts of biologically active plants are an effective nanomaterial that needs to be comprehensively investigated for implementation into medical practice. In this study, the synergistic effects arising from their combined use with antibiotics and fungicides against various bacteria and yeasts were studied. The following methods were used: disco-diffusion analysis and construction of plankton culture growth curves. The synergistic effect of silver nanoparticles and antibiotics (fungicides) has been determined. Effective concentrations of substances were established, recommendations for the studied pathogenic species were presented, and the effect of destruction of the bacterial membrane was illustrated. The most significant synergistic effect was manifested in pathogenic candida and brewer's yeast.
Collapse
Affiliation(s)
- Artem Rozhin
- Institute of Fundamental Medicine and Biology, Kazan Federal University, Kreml Str. 18, 420008 Kazan, Russia; (S.B.); (L.I.)
| | - Svetlana Batasheva
- Institute of Fundamental Medicine and Biology, Kazan Federal University, Kreml Str. 18, 420008 Kazan, Russia; (S.B.); (L.I.)
- Institute for Regenerative Medicine, Sechenov University, Trubetskaya Str. 8/2, 119992 Moscow, Russia
| | - Liliya Iskuzhina
- Institute of Fundamental Medicine and Biology, Kazan Federal University, Kreml Str. 18, 420008 Kazan, Russia; (S.B.); (L.I.)
| | - Marina Gomzikova
- Institute of Fundamental Medicine and Biology, Kazan Federal University, Kreml Str. 18, 420008 Kazan, Russia; (S.B.); (L.I.)
| | - Marina Kryuchkova
- Institute of Fundamental Medicine and Biology, Kazan Federal University, Kreml Str. 18, 420008 Kazan, Russia; (S.B.); (L.I.)
| |
Collapse
|
3
|
Karthik C, Sarngadharan SC, Thomas V. Low-Temperature Plasma Techniques in Biomedical Applications and Therapeutics: An Overview. Int J Mol Sci 2023; 25:524. [PMID: 38203693 PMCID: PMC10779006 DOI: 10.3390/ijms25010524] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2023] [Revised: 12/04/2023] [Accepted: 12/25/2023] [Indexed: 01/12/2024] Open
Abstract
Plasma, the fourth fundamental state of matter, comprises charged species and electrons, and it is a fascinating medium that is spread over the entire visible universe. In addition to that, plasma can be generated artificially under appropriate laboratory techniques. Artificially generated thermal or hot plasma has applications in heavy and electronic industries; however, the non-thermal (cold atmospheric or low temperature) plasma finds its applications mainly in biomedicals and therapeutics. One of the important characteristics of LTP is that the constituent particles in the plasma stream can often maintain an overall temperature of nearly room temperature, even though the thermal parameters of the free electrons go up to 1 to 10 keV. The presence of reactive chemical species at ambient temperature and atmospheric pressure makes LTP a bio-tolerant tool in biomedical applications with many advantages over conventional techniques. This review presents some of the important biomedical applications of cold-atmospheric plasma (CAP) or low-temperature plasma (LTP) in modern medicine, showcasing its effect in antimicrobial therapy, cancer treatment, drug/gene delivery, tissue engineering, implant modifications, interaction with biomolecules, etc., and overviews some present challenges in the field of plasma medicine.
Collapse
Affiliation(s)
- Chandrima Karthik
- Department of Materials & Mechanical Engineering, University of Alabama at Birmingham, 1150 10th Avenue South, Birmingham, AL 35205, USA;
| | | | - Vinoy Thomas
- Department of Materials & Mechanical Engineering, University of Alabama at Birmingham, 1150 10th Avenue South, Birmingham, AL 35205, USA;
| |
Collapse
|